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High-Normal Blood Pressure and Cognition: Supplying the Missing Data
To the Editor:
In the March 2008 issue of Hypertension, Knecht et al 1 report that high-normal blood pressure is associated with poor cognitive performance. Predicted means of a global cognitive performance measure were plotted against mean systolic blood pressure (BP; SBP) values for a sample (Nϭ377; mean age: 64 years) defined by the following categories: Ͻ120, 120 to 130, 130 to 140, 140 to 150, 150 to 160, 160 to 170, and Ͼ170 mm Hg. Cognitive performance decreased from the lowest BP grouping to 160 to 170 mm Hg. This inverse linear relation between SBP and cognition has been described previously. [2] [3] [4] Knecht et al 1 note that the inverse relation between SBP and cognition passes through the reference range of BP values (Figure 2 ), but they did not relate SBP to cognitive performance in analyses limited to only those persons within the reference range of systolic and diastolic BP values, analyses that are necessary to more precisely estimate the decrement in cognitive performance for persons within the normal BP range. Knecht et al 1 measured SBP and cognition concurrently at a single examination, a limitation that they note. Although data on several domains of cognitive performance were obtained, findings were reported only for a global composite score.
Using data from the Maine-Syracuse Longitudinal Study, we performed each of the missing analyses noted above. These analyses provide important additional support for the Knecht et al 1 finding.
Initiated in 1975, the Maine-Syracuse Longitudinal Study involves 6 waves of data collection on BP and BP-related risk factors in a community-based sample. [3] [4] [5] In our analysis, we relate the average of all of the available SBP measurements from wave 1 through wave 6 (15 measurements per wave) to an expanded set of cognitive performance measures introduced at wave 6 (2001-2007). 5 We used 4 composite scores (cognitive domains) and a single measure of abstract reasoning (Similarities) based on previous factor analysis involving 17 individual cognitive measures. 5 Excluding persons with a history of stroke (nϭ35) 3 Antihypertensive drug treatment by BP interactions for all of the cognitive performance measures were nonsignificant (PsϾ0.10); thus, the treated and untreated individuals were combined in the analyses. Our statistical analyses included sets of covariates used by Knecht et al 1 : (1) basic set (sex, age, and education); (2) basic set plus risk factors (body mass index plus alcohol consumption plus cigarettes plus total cholesterol); and (3) basic set plus risk factors plus antihypertensive drugs (yes or no).
The Table shows the relation between 10-mm Hg increments in mean SBP and cognitive performance in SD units. Increments in SBP were inversely related to the level of cognitive performance. The fewest number of cognitive variables related to performance was obtained with adjustment for the basic plus risk factor plus antihypertensive drug treatment model: global performance, verbal memory, and working memory.
Given that our analyses were confined to the participants with normal to high-normal BP, we can estimate decrements in cognitive performance relative to each 10-mm Hg increment in SBP. Using the basic model and global performance as an illustration, every 10-mm Hg increment in SBP was related to a 0.075-SD decrement in cognitive performance. The 95% CI was Ϫ0.12 to Ϫ0.02. Our results indicate that SBP-related cognitive 
